Spots Global Cancer Trial Database for ovary
Every month we try and update this database with for ovary cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Awareness and Attitudes Regarding Prenatal and Preimplantation Genetic Diagnosis for Inherited Breast/Ovarian Cancer Risk | NCT00735150 | Breast Cancer Ovarian Cancer | questionnaire, ... | 18 Years - 39 Years | Memorial Sloan Kettering Cancer Center | |
| Open Label Immunotherapy Trial for Ovarian Cancer | NCT03556566 | Ovarian Cancer | Tableted vaccin... | 18 Years - 65 Years | Immunitor LLC | |
| Maintenance Treatment for Ovarian Carcinoma in Remission by an Antiangiogenic Treatment Strategy | NCT01175772 | Ovarian Carcino... | Cytophosphan, C... | 20 Years - 80 Years | HaEmek Medical Center, Israel | |
| Tivozanib in Recurrent, Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer | NCT01853644 | Recurrent Epith... Recurrent Fallo... Recurrent Prima... | Tivozanib | 18 Years - 110 Years | Northwestern University | |
| Tissue Acquisition for Molecular Diagnostics | NCT00001580 | Neoplasm | - | National Institutes of Health Clinical Center (CC) | ||
| Combining Interventions of Fertility Preservation to Mitigate Fertility Loss After Breast Cancer | NCT04586686 | Breast Cancer F... | Ovarian biopsy ... Transvaginal oo... | 18 Years - 35 Years | Universitair Ziekenhuis Brussel | |
| Polyvalent Vaccine-KLH Conjugate + Opt-821 Given in Combination With Bevacizumab | NCT01223235 | Fallopian Tubes... Ovarian Cancer Peritoneal Canc... | bevacizumab and... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Evaluating the Performance of Morphology Index in Surgical Decision-Making for Ovarian Tumors | NCT02227654 | Ovarian Neoplas... | Abnormal Ovaria... | 25 Years - | University of Kentucky | |
| Phase 3 Randomized Study of Telcyta + Doxorubicin Versus Doxorubicin in Platinum Refractory or Resistant Ovarian Cancer | NCT00350948 | Ovarian Neoplas... | Telcyta Liposomal Doxor... | 18 Years - | Telik | |
| Intraperitoneal tgDCC-E1 and Intravenous Paclitaxel in Women With Platinum-Resistant Ovarian Cancer | NCT00102622 | Ovarian Cancer | Intraperitoneal... Paclitaxel | 18 Years - | M.D. Anderson Cancer Center | |
| Fermented Wheat Germ Extract in Women With Ovarian Cancer | NCT02411565 | Ovarian Cancer | Fermented Wheat... Placebo Standard of Car... Quality of Life... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Accelerating Gastrointestinal Recovery | NCT01704651 | Ovarian Cancer Fallopian Tube ... Peritoneal Canc... | Alvimopan Placebo | 18 Years - | Mayo Clinic | |
| Maintenance Treatment for Ovarian Carcinoma in Remission by an Antiangiogenic Treatment Strategy | NCT01175772 | Ovarian Carcino... | Cytophosphan, C... | 20 Years - 80 Years | HaEmek Medical Center, Israel | |
| EPO906 Therapy in Patients With Advanced Ovarian, Primary Fallopian, or Primary Peritoneal Cancer | NCT00035100 | Ovarian Neoplas... Peritoneal Neop... Fallopian Tube ... | epothilone b | 18 Years - | Novartis | |
| Thermal Spread Into the Interstitial Portion of the Fallopian Tubes Using the Ligasure Device at Time of Hysterectomy | NCT00746018 | Cervical Cancer Ovarian Cancer Uterine Cancer | LigaSure vessel... | 21 Years - | Memorial Sloan Kettering Cancer Center | |
| Prophylactic Salpingectomy With Delayed Oophorectomy | NCT01907789 | Ovarian Carcino... | Ovarian Cancer ... Prophylactic Sa... Risk-Reducing S... Questionnaire Transvaginal Ul... Phone Call | 30 Years - 47 Years | M.D. Anderson Cancer Center | |
| Impact of Cardiac Coherence on Anxiety in Patients Operated on for a Peritoneal Carcinosis | NCT04024917 | Peritoneal Carc... Pseudomyxoma Pe... Mesothelioma Pe... | Cardiac coheren... Standard care | 18 Years - | Institut du Cancer de Montpellier - Val d'Aurelle | |
| Nutritional and Metabolic Correlates of Ovarian Morphology in Women With Polycystic Ovary Syndrome | NCT01927471 | Polycystic Ovar... Menstrual Irreg... | 18 Years - 48 Years | Cornell University | ||
| Bioequivalence Study of SPARC147609 in Patients With Ovarian Cancer | NCT00862355 | Ovarian Carcino... | SPARC147609 Reference147609 | 18 Years - | Sun Pharma Advanced Research Company Limited | |
| Combining Interventions of Fertility Preservation to Mitigate Fertility Loss After Breast Cancer | NCT04586686 | Breast Cancer F... | Ovarian biopsy ... Transvaginal oo... | 18 Years - 35 Years | Universitair Ziekenhuis Brussel | |
| Intravenous and Intraperitoneal Paclitaxel, Intraperitoneal Cisplatin, and Intravenous Bevacizumab for the Initial Treatment of Optimal Stage II or III Ovarian, Primary Peritoneal, and Fallopian Tube Cancer | NCT00588237 | Ovarian Cancer Primary PERITON... Fallopian Tube ... | Paclitaxel,Cisp... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Theca Cell Function in Adolescents With Polycystic Ovary Syndrome (PCOS) | NCT01154192 | PCOS | Dexamethasone recombinant hum... | 12 Years - 18 Years | University of California, San Diego | |
| Structural and Functional Imaging and Cognitive Functions in Ovarian Cancer | NCT01591772 | Fallopian Tube ... Ovarian Cancer Peritoneal Canc... | Neuroimaging & ... Neuroimaging & ... | 21 Years - 70 Years | Memorial Sloan Kettering Cancer Center | |
| Prospective Validation and Comparison of Different Ultrasound Methods for Discrimination Between Benign and Malignant Ovarian/Tubal Masses Prior to Surgery | NCT02847832 | Patients With A... | Standardized tr... | - | KU Leuven | |
| Gynecologic Cancer Lymphedema Questionnaire as a Clinical Care Tool to Identify Lower Extremity Lymphedema | NCT00944944 | Ovarian Cancer Uterine Cancer Vaginal Cancer Lymphedema | limb volume mea... GCLQ lymphedema... | 21 Years - | Memorial Sloan Kettering Cancer Center | |
| Tivozanib in Recurrent, Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer | NCT01853644 | Recurrent Epith... Recurrent Fallo... Recurrent Prima... | Tivozanib | 18 Years - 110 Years | Northwestern University | |
| Motion Correction in Dynamic Contrast Enhanced Magnetic Resonance Imaging (MRI) in Ovarian Cancer: A Pilot Study | NCT00946140 | Ovarian Cancer | DCE-MRI scans | 21 Years - | Memorial Sloan Kettering Cancer Center | |
| Prophylactic Salpingectomy With Delayed Oophorectomy | NCT01907789 | Ovarian Carcino... | Ovarian Cancer ... Prophylactic Sa... Risk-Reducing S... Questionnaire Transvaginal Ul... Phone Call | 30 Years - 47 Years | M.D. Anderson Cancer Center | |
| Ovarian Ultrasonography for the Clinical Evaluation of Polycystic Ovary Syndrome | NCT03547453 | Polycystic Ovar... Menstrual Irreg... Overweight and ... | 18 Years - | Cornell University | ||
| Narrow Band Imaging (NBI): A Novel Imaging Modality in Minimally Invasive | NCT01262040 | Endometrial Can... Fallopian Tube ... Ovarian Cancer Peritoneal Canc... Gastrointestina... Pancreatic Carc... Lung Cancer Esophageal Carc... | Narrow Band Ima... | 19 Years - | Memorial Sloan Kettering Cancer Center | |
| Awareness and Attitudes Regarding Prenatal and Preimplantation Genetic Diagnosis for Inherited Breast/Ovarian Cancer Risk | NCT00735150 | Breast Cancer Ovarian Cancer | questionnaire, ... | 18 Years - 39 Years | Memorial Sloan Kettering Cancer Center | |
| Intraperitoneal tgDCC-E1 and Intravenous Paclitaxel in Women With Platinum-Resistant Ovarian Cancer | NCT00102622 | Ovarian Cancer | Intraperitoneal... Paclitaxel | 18 Years - | M.D. Anderson Cancer Center | |
| The RECHARGE Low Carbohydrate Diet Trial for Metastatic Cancer | NCT00444054 | Cancer Breast Cancer Colon Cancer Cervical Cancer Uterine Cancer Ovarian Cancer | Very low carboh... | 21 Years - | Albert Einstein College of Medicine | |
| Motion Correction in Dynamic Contrast Enhanced Magnetic Resonance Imaging (MRI) in Ovarian Cancer: A Pilot Study | NCT00946140 | Ovarian Cancer | DCE-MRI scans | 21 Years - | Memorial Sloan Kettering Cancer Center | |
| A Study of Liposomal Doxorubicin With or Without Olaratumab (IMC-3G3) in Platinum-Refractory or Resistant Advanced Ovarian Cancer | NCT00913835 | Ovarian Neoplas... | Olaratumab liposomal doxor... | 18 Years - | Eli Lilly and Company | |
| Motion Correction in Dynamic Contrast Enhanced Magnetic Resonance Imaging (MRI) in Ovarian Cancer: A Pilot Study | NCT00946140 | Ovarian Cancer | DCE-MRI scans | 21 Years - | Memorial Sloan Kettering Cancer Center | |
| Polyvalent Vaccine-KLH Conjugate + Opt-821 Given in Combination With Bevacizumab | NCT01223235 | Fallopian Tubes... Ovarian Cancer Peritoneal Canc... | bevacizumab and... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Bioequivalence Study of SPARC147609 in Patients With Ovarian Cancer | NCT00862355 | Ovarian Carcino... | SPARC147609 Reference147609 | 18 Years - | Sun Pharma Advanced Research Company Limited | |
| Gynecologic Cancer Lymphedema Questionnaire as a Clinical Care Tool to Identify Lower Extremity Lymphedema | NCT00944944 | Ovarian Cancer Uterine Cancer Vaginal Cancer Lymphedema | limb volume mea... GCLQ lymphedema... | 21 Years - | Memorial Sloan Kettering Cancer Center | |
| Safety and Efficacy of Interferon Gamma-1b Plus Chemotherapy for Ovarian and Peritoneal Cancer | NCT00047632 | Ovarian Carcino... Peritoneal Carc... | Interferon gamm... | - | InterMune | |
| Effect of Increased Circulating Androgens on Granulosa Cell Responses to FSH. | NCT02389088 | Polycystic Ovar... | Letrozole | 18 Years - 40 Years | University of California, San Diego | |
| The RECHARGE Low Carbohydrate Diet Trial for Metastatic Cancer | NCT00444054 | Cancer Breast Cancer Colon Cancer Cervical Cancer Uterine Cancer Ovarian Cancer | Very low carboh... | 21 Years - | Albert Einstein College of Medicine | |
| Low Dose Upper Abdominal Radiation Therapy (LD-UART) + Gemcitabine in Patients With Advanced, Unresectable Pancreatic Cancer (PC) | NCT00390182 | Gastrointestina... Ovarian Neoplas... | Gemcitabine | 18 Years - | University of Maryland, Baltimore | |
| Safety and Efficacy Clinical Study of SNS-595 in Patients With Platinum-Resistant Ovarian Cancer | NCT00408603 | Epithelial Ovar... | Voreloxin Injec... | 18 Years - | Sunesis Pharmaceuticals | |
| Ancillary Study GOG 158: Survival Analysis Based on Reclassification to a Two-Tier Grading System | NCT00837993 | Ovarian Cancer | - | M.D. Anderson Cancer Center | ||
| Narrow Band Imaging (NBI): A Novel Imaging Modality in Minimally Invasive | NCT01262040 | Endometrial Can... Fallopian Tube ... Ovarian Cancer Peritoneal Canc... Gastrointestina... Pancreatic Carc... Lung Cancer Esophageal Carc... | Narrow Band Ima... | 19 Years - | Memorial Sloan Kettering Cancer Center | |
| TLK286 (Telcyta) in Combination With Carboplatin (Paraplatin) Versus Doxil in Platinum Refractory or Resistant Ovarian Cancer | NCT00102973 | Ovarian Neoplas... | TLK286 in Combi... Doxorubicin HCl... | 18 Years - | Telik | |
| Evaluating the Performance of Morphology Index in Surgical Decision-Making for Ovarian Tumors | NCT02227654 | Ovarian Neoplas... | Abnormal Ovaria... | 25 Years - | University of Kentucky | |
| TLK286 (Telcyta) in Combination With Carboplatin (Paraplatin) Versus Doxil in Platinum Refractory or Resistant Ovarian Cancer | NCT00102973 | Ovarian Neoplas... | TLK286 in Combi... Doxorubicin HCl... | 18 Years - | Telik | |
| Safety Study of a Liposomal Docetaxel Formulation in Patients With Solid Tumors Who Have Failed Previous Therapies | NCT01041235 | Solid Tumor Breast Cancer Ovarian Cancer Pancreatic Canc... Non-Small Cell ... | ATI-1123 (activ... | 18 Years - | Azaya Therapeutics, Inc. | |
| Tivozanib in Recurrent, Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer | NCT01853644 | Recurrent Epith... Recurrent Fallo... Recurrent Prima... | Tivozanib | 18 Years - 110 Years | Northwestern University | |
| TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer | NCT00057720 | Ovarian Neoplas... | TLK286 HCl for ... topotecan hydro... doxorubicin HCl... | 18 Years - | Telik | |
| A Study of Liposomal Doxorubicin With or Without Olaratumab (IMC-3G3) in Platinum-Refractory or Resistant Advanced Ovarian Cancer | NCT00913835 | Ovarian Neoplas... | Olaratumab liposomal doxor... | 18 Years - | Eli Lilly and Company | |
| Ancillary Study GOG 158: Survival Analysis Based on Reclassification to a Two-Tier Grading System | NCT00837993 | Ovarian Cancer | - | M.D. Anderson Cancer Center | ||
| Clinical Benefit of Topoisomerase Downregulation | NCT00250094 | Ovarian Cancer | Topotecan and V... | 18 Years - | New Mexico Cancer Care Alliance | |
| ROCKIF Trial: Re-sensitization of Carboplatin-resistant Ovarian Cancer With Kinase Inhibition of FAK | NCT03287271 | Ovarian Cancer | VS-6063 Paclitaxel Carboplatin | 18 Years - | University of California, San Diego |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
